Latest news
Loading news…
Refuge Biotechnologies
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Menlo Park, California, United States Founded 2015 11-50 employees For Profit
Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
10
Patents
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $50M to $100M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- Patents granted
- 7
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $525K
Company Info
- Founded
- 2015
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 12
- HQ
- Menlo Park, California, United States
- Region
- San Francisco Bay Area, Silicon Valley, West Coast
- Closed
- Aug 3, 2023
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.7
- Trend (90d)
- 2.9
10
professional contacts at Refuge Biotechnologies
Contact execs at Refuge Biotechnologies →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Refuge Biotechnologies
Loading news…
FAQs about Refuge Biotechnologies
People who checked this page also checked these
Browse the full Acquirezy directory.